We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$48.3B
AUM Growth
-$47.5M
Cap. Flow
+$293M
Cap. Flow %
0.61%
Top 10 Hldgs %
19.42%
Holding
2,220
New
160
Increased
1,052
Reduced
474
Closed
103

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$94.9M
2
SBUX icon
Starbucks
SBUX
+$69.4M
3
SJM icon
J.M. Smucker
SJM
+$65.7M
4
ARKK icon
ARK Innovation ETF
ARKK
+$64M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$60M

Top Sells

Rank Stock Value
1
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$177M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$112M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$103M
4
BDX icon
Becton Dickinson
BDX
+$80.7M
5
AXP icon
American Express
AXP
+$73.9M

Sector Composition

Rank Sector Weight
1 Technology 23.22%
2 Financials 13.94%
3 Healthcare 12.69%
4 Consumer Discretionary 11.51%
5 Communication Services 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSBC icon
1251
Old Second Bancorp
OSBC
$1.31B
$2.32M ﹤0.01%
177,747
– –
INGN icon
1252
Inogen
INGN
$154M
$2.31M ﹤0.01%
53,600
+6,500
+14% +$400K
CHWY icon
1253
Chewy
CHWY
$9.15B
$2.3M ﹤0.01%
33,815
+5,552
+20% +$460K
VEON icon
1254
VEON
VEON
$3.92B
$2.3M ﹤0.01%
44,277
+3,320
+8% +$160K
ALLO icon
1255
Allogene Therapeutics
ALLO
$683M
$2.26M ﹤0.01%
88,000
– –
QNCX icon
1256
Quince Therapeutics
QNCX
$31.8M
$2.25M ﹤0.01%
123
+17
+16% +$270K
TRIL
1257
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.22M ﹤0.01%
126,500
+1,758
+1% +$20.5K
VIPS icon
1258
Vipshop
VIPS
$6.94B
$2.21M ﹤0.01%
198,744
-358,831
-64% -$5.64M
IOSP icon
1259
Innospec
IOSP
$2.31B
$2.21M ﹤0.01%
26,200
-54,200
-67% -$4.83M
SMPL icon
1260
Simply Good Foods
SMPL
$968M
$2.2M ﹤0.01%
63,866
– –
KYMR icon
1261
Kymera Therapeutics
KYMR
$9.51B
$2.2M ﹤0.01%
37,400
– –
VHAQ
1262
DELISTED
Viveon Health Acquisition Corp.
VHAQ
$2.2M ﹤0.01%
219,950
+2,551
+1% +$25.4K
ONC
1263
BeOne Medicines Ltd
ONC
$40.6B
$2.17M ﹤0.01%
5,992
– –
ACAHU
1264
DELISTED
Atlantic Coastal Acquisition Corp. Unit
ACAHU
$2.17M ﹤0.01%
220,002
+8,002
+4% +$79.5K
AVAN
1265
DELISTED
Avanti Acquisition Corp.
AVAN
$2.15M ﹤0.01%
+220,000
New +$2.14M
ZLAB icon
1266
Zai Lab
ZLAB
$2.86B
$2.15M ﹤0.01%
20,395
-5,898
-22% -$847K
KRC icon
1267
Kilroy Realty
KRC
$4.22B
$2.14M ﹤0.01%
32,279
+3,435
+12% +$232K
CLAA.U
1268
DELISTED
Colonnade Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
CLAA.U
$2.13M ﹤0.01%
220,000
+5,504
+3% +$54.6K
EBIX
1269
DELISTED
Ebix Inc
EBIX
$2.13M ﹤0.01%
79,100
– –
ENTG icon
1270
Entegris
ENTG
$24.6B
$2.13M ﹤0.01%
16,876
+794
+5% +$95.7K
ISEE
1271
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.12M ﹤0.01%
130,700
+17,500
+15% +$190K
RVMD icon
1272
Revolution Medicines
RVMD
$44B
$2.11M ﹤0.01%
76,800
– –
HTPA.U
1273
DELISTED
Highland Transcend Partners I Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
HTPA.U
$2.07M ﹤0.01%
198,000
-2,000
-1% -$20.2K
RGNX icon
1274
Regenxbio
RGNX
$720M
$2.05M ﹤0.01%
49,000
– –
ALXO icon
1275
ALX Oncology
ALXO
$278M
$2.04M ﹤0.01%
27,600
+4,100
+17% +$273K
49 50
51
52 53

Similar funds

TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
RIM
Rakuten Investment Management Tokyo, Japan $49.2B AUM

State of Wisconsin Investment Board's Q3 2021 Portfolio in Review

As of Q3 2021, State of Wisconsin Investment Board held 2,220 positions worth $48.3B, down 0.1% from $48.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

State of Wisconsin Investment Board's Q3 2021 filing shows 160 new, 1,052 increased, 474 reduced and 103 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 438,532 shares worth $32.6M. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $177M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • State of Wisconsin Investment Board's largest Q3 2021 buy was iShares Core MSCI EAFE ETF: 438,532 shares worth $32.6M.
  • State of Wisconsin Investment Board added most to Pfizer in Q3 2021, an estimated $94.9M increase.
  • State of Wisconsin Investment Board's biggest Q3 2021 reduction was Royal Dutch Shell PLC ADS Class B, cutting an estimated $177M.
  • State of Wisconsin Investment Board fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $103M.
  • State of Wisconsin Investment Board's ten largest holdings make up 19% of its $48.3B portfolio in Q3 2021.
  • State of Wisconsin Investment Board opened 160 new positions and closed 103 in Q3 2021.
  • State of Wisconsin Investment Board's portfolio value fell 0.1% quarter-over-quarter to $48.3B.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2021, filed 12 Nov 2021.